Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Study results from C.K. Daugherty et al provide new insights into cancer
May 12th, 2008
According to a study from the United States, " To examine the ethical, scientific, and regulatory issues in the design and conduct of placebo-controlled cancer clinical trials. Several content experts contributed to this article." " Specific criteria can be applied to determine the appropriate use of placebos in oncology drug development. Placebo controls may be justified to prove efficacy of a new treatment in diseases with high placebo response rates; in conditions that wax and wane in severity, have spontaneous remissions, or have an uncertain and unpredictable course; when existing therapies are minimally effective or have serious adverse effects; or in the absence...
Source: Biotech Business Week (2008-05-12)
|
